CME vs SPGI
CME Group and S&P Global, both Financial Services
S&P Global is the larger company at $122B against $89B. On trailing earnings CME is the cheaper of the two at a P/E of 23.8 against 25.8, a gap that is only a bargain if the two are growing at similar rates. Over the past year CME returned +11% against -19% for SPGI. The RyuScore puts CME ahead, 64 against 61 out of 100.
| Figure | CME | SPGI |
|---|---|---|
| Last close | $281 | $408 |
| Market cap | $89B | $122B |
| Trailing P/Elower is cheaper for the same earnings, not automatically better | 23.8 | 25.8 |
| Dividend yield | 1.8% | 1.0% |
| 1-year return | +11% | -19% |
| 5-year return | +82% | -5.5% |
| RyuScoresector-relative, 1–10 | 64/100 | 61/100 |
Figures from SEC filings and end-of-day closes. Highlighting marks the higher or lower number, which is not the same as the better investment, a low P/E can be a warning and a high one can be deserved.
CME Group
Revenue of $1.7B in Q2 2026, net income $1.0B. Its largest reported line is Clearingandtransactionfees, 79% of the disclosed total.
S&P Global
Revenue of $4.2B in Q1 2026, net income $1.4B. Its largest reported line is Ratings, 31% of the disclosed total.
Open these two in the interactive comparison to add more names, change the period or see the correlation.